We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Optibiotix Health Plc | LSE:OPTI | London | Ordinary Share | GB00BP0RTP38 | ORD 2P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-1.25 | -7.46% | 15.50 | 15.00 | 16.00 | 16.75 | 15.50 | 16.75 | 595,508 | 10:34:59 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Noncomml Resh Organizations | 644k | -2.04M | -0.0208 | -7.45 | 16.41M |
Date | Subject | Author | Discuss |
---|---|---|---|
08/11/2016 18:30 | Hey I don't understand the science and I bet there aren't that many in the world that actually do I get the theory behind it. That's about it | judijudi | |
08/11/2016 18:15 | Ok Mazz you win, I will not post any more information on here as I you are right I do not know the science but I bet you would have struggled with the in depth topic not just on the sugars and skin. I only gave the information as a friend which I thought we were? but with the remarks you and Judy made I will not pass on any more information, for all my posts you are all Welcome. Diamond. | diamond fibre | |
08/11/2016 17:42 | Doesn't understand the science but ramps the share price anyway. I can't say anymore about this fool. | mazzstar | |
08/11/2016 14:52 | Mazz,show me where I did not know that a ticket was £1299?. For your information I did not pay for my ticket, read into that what you want, the presentation was out of my league as far as the science goes, but I did chat to SOH after and was impressed, but like I said buy buy buy was my personal view (which was proved to be wrong} I agree with you all in the sense that until we sign a big deal we are going to float around the 60-70 mark. and I say that with a smile, all the best Diamond. xxxx | diamond fibre | |
08/11/2016 14:03 | (link fixed) A common food additive used to extend shelf life promotes the growth of colon cancer in mice, according to a new study. Emulsifiers are added to most processed foods to aid texture and keep them fresh but the findings of the US study, published in journal Cancer Research, suggests they are toxic to the body and potentially deadly. Researchers at Georgia State University found regular consumption of dietary emulsifiers in mice exacerbated tumour development. It's believed the emulsifiers alter the microbiota inside the intestines to create the ideal conditions for cancer growth.............. see also: | maxwellsdemon | |
08/11/2016 13:52 | well bought the 3 week pack of go figure on amazon ... should be delivered next week. will report back on results !!! maybe should have done that before buying the shares lols !!!!! | meganxmas | |
08/11/2016 13:48 | Stop asking diamond about the event, he never went he's just lying. The fool wasn't even aware that a ticket cost £1,299. | mazzstar | |
08/11/2016 13:24 | diamond - despite the fact that readers on this BB have a keen interest in SOH's presentation, none of us have been able to see it or find any feedback from anyone who was present. Therefore, it is highly unlikely that someone with less interest in OPTI will know anything about it, which answers your question why the share price has not gone up (however brilliant it may have been). Anyhow, the market has become numb to SOH presentations over the past 12 months and usually react negatively. The only SOH presentation that will have a positive effect on the share price will be one that contains hard commercial news, and I very much doubt his one on Friday did. | kipper1960 | |
08/11/2016 13:22 | diamond was signing on, on the day of the presentation :) | judijudi | |
08/11/2016 13:10 | Diamond said he was attending but hasn't given any feedback. I also asked the question the other day but it hasn't been answered | primal123 | |
08/11/2016 13:02 | diamond - on what basis was it 'brilliant' did you see it in person? Best wishes - Mike | spike_1 | |
08/11/2016 12:59 | I can not understand why we are not going up after a brilliant presentation by SOH? | diamond fibre | |
08/11/2016 09:54 | Back to the 50 day SMA...now, if we could just squeeze up to 71.50p, that would be quite bullish. Is it too much to ask for? M | marnewton | |
08/11/2016 09:25 | Spring begins in March. So not long before OPTI launch their game-changing cardiovascular products... "Life sciences group OptiBiotix Health plc (LON:OPTI) is targeting spring next year to launch a range of cardiovascular products to reduce cholesterol and blood pressure. Optibiotix says it has a range of product formulations, and a supporting distribution and sales structure with partners to support the launch." | someuwin | |
08/11/2016 09:06 | Not today though :-) | elrico | |
08/11/2016 08:32 | Still think we'll see 90p before we see 100p ;) | owenmo | |
08/11/2016 07:00 | INFORMATION ABOUT US www.slimfast.co.uk is a site operated by KSF Acquisition UK Limited (We). We are registered in England and Wales under company number 09112415 and have our registered office at 3, Queen's Square, Ascot Business Park, Lyndhurst Road, Ascot, SL5 9FE, UK. Our VAT number is GB196257568. - See more at: | mirandaj | |
08/11/2016 01:01 | Followed Someuwin's link, I found the following on the site. I might be way off the mark but this sounds like it could be us.. http://www.nizo.com/ | 1bokke | |
07/11/2016 22:06 | Yes - I wasn't aware of NIZO working on skin microbiome product development. But this link shows they're all over it like...er a rash: | someuwin | |
07/11/2016 20:56 | Thanks for clearing that up, mouse. I hadn't seen the link. I don't ever recall NIZO being linked with Skinbiotix - I had always had NIZO down as sugars related. Risky - I have sang the same tune for some time, since GoFigure was launched, c12 months ahead of my expectations and I don't recall anyone else expecting it any earlier. I have to say though - I did not expect today's price drop. 1-2p perhaps. | elrico | |
07/11/2016 19:45 | The same Nizo logo was shown on the same chart in the year end accounts on page 11 hxxp://www.optibioti Accounts were published back in April. Nothing has changed on the chart since then. | mouse20 | |
07/11/2016 19:18 | I think Tom winnifreth has played a major part in certain investors disappointments in terms of expectations. Remember he was stating a massive deal with supposedly png was going to happen a month after the invention had been clinically validated. I've been in from near the start and my expectations have been more than met so far. The dsm deal is a concrete deal that will lead to revenues in the not so distant future. The fact we have these deals in place so early is excellent for such an early stage company. Try finding another company on AIM to achieve so much within 2 years of listing | riskybusiness1 | |
07/11/2016 19:05 | owenmo - It is my opinion SOH released the 'commercial update' RNS in the last week of October to offer the market and shareholders some comfort that things are progressing and that we should expect deals in the new year rather than this month. Who knows why deals have yet to materialise; the last thing we need this month is a RNS confirming so! | mazzstar | |
07/11/2016 18:45 | The Cleveland Clinic observations are most welcome; I would say, however, and who would argue, that it behoves SOH, in light of earlier-in-the-year stated aspirations, to deliver something concrete in November or otherwise offer comfort as to why expectation hasn't as yet materialised. | owenmo | |
07/11/2016 18:39 | Someuwin - I don't ever recall NIZO ever being mentioned in the same sentence as Skinbiotix. NIZO appears to be linked to Skinbiotix and Slimbiome....this is new, is it not. I guess this was what you were alluding in 17218. | elrico |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions